Managers / Q1 2026
Kentucky Trust Co
CIK 0002054100 · 218 W MAIN ST, DANVILLE, KY, 40422 · 859-239-9000
Summary
Kentucky Trust Co reported $191M in U.S.-listed holdings across 311 positions for Q1 2026.
Its largest position, USB, represents 4.3% of the portfolio.
Compared with Q4 2025, the fund opened 18 new positions and exited 11.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 81.9% · $156M
- ETP · 8.5% · $16M
- Closed-End Fund · 3.8% · $7M
- REIT · 3.4% · $6M
- ADR · 1.2% · $2M
- Other · 1.2% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TJXTJX Companies | NEW | +162 | 162 | +$25,871 | $25,871 |
| SNASnap-on | NEW | +40 | 40 | +$14,529 | $14,529 |
| KDPKeurig Dr Pepper Inc | NEW | +541 | 541 | +$14,245 | $14,245 |
| SMRNuScale Power Corporation | NEW | +500 | 500 | +$5,420 | $5,420 |
| GXRPGrayscale XRP Trust ETF | NEW | +200 | 200 | +$5,204 | $5,204 |
| VRTXVertex Pharmaceuticals, Inc. | NEW | +5 | 5 | +$2,233 | $2,233 |
| MUMicron Technology | NEW | +6 | 6 | +$2,027 | $2,027 |
| NEMNewmont Corp | NEW | +14 | 14 | +$1,516 | $1,516 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $191M | 311 | Apr 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $189M | 304 | Jan 21, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $185M | 294 | Oct 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $174M | 297 | Jul 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $168M | 299 | Apr 21, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $170M | 303 | Jan 29, 2025 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.